News
CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Evolva ...
BRUSSELS, BE / ACCESS Newswire / July 3, 2025 / Brussels transformed into a Champions League pitch for tobacco harm reduction as the World Vapers' Alliance (WVA) honoured Sweden, the Czech Republic, ...
VANCOUVER, BC / ACCESS Newswire / July 2, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that on July 2, 2025, ...
SAN FRANCISCO, CA / ACCESS Newswire / July 2, 2025 / The Bay Area CBT Center has unveiled a groundbreaking offering: fully ...
Regeneron Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ...
STOCKHOLM, SE / ACCESS Newswire / July 2, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - At an extraordinary general meeting in AlzeCure Pharma AB on July 2, 2025, the shareholders decided to approve ...
Aurobindo Pharma’s Dazublys, a trastuzumab biosimilar for HER2-positive cancers, gains EU approval, enhancing access to ...
Alvotech and Advanz Pharma expand their European biosimilar partnership to include AVT10, targeting Cimzia® for rheumatic ...
Northern Ireland-based Sepha, a global leader in pharmaceutical packaging testing, has commenced construction of its new state of the art headquarters on Comber Road in Dundonald just outside Belfast.
Stefan Oelrich, President of the European Federation of Pharmaceutical Industries and Associations (EFPIA), has called for ...
Open House Highlights Expanded Sterile Filling Contract Manufacturing Capabilities for Small and Large Molecules Pace Life Sciences Salem Renderings ...
Legislative Threats to Medicaid Funding Drive 300+ Vulnerable Hospitals to Reevaluate Financial Resilience, Operations, and Community Impact WASHINGTON, DC / ACCESS Newswire / July 2, 2025 / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results